{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T16:57:45Z","timestamp":1777395465817,"version":"3.51.4"},"update-to":[{"DOI":"10.1002\/14651858.cd012481","type":"new_version","label":"New version","source":"publisher","updated":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T00:00:00Z","timestamp":1503446400000}}],"reference-count":228,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T00:00:00Z","timestamp":1503446400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T00:00:00Z","timestamp":1503446400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions"}],"content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd012481.pub2","type":"journal-article","created":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T14:23:28Z","timestamp":1503498208000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Drug-eluting stents versus bare-metal stents for acute coronary syndrome"],"prefix":"10.1002","volume":"2021","author":[{"given":"Joshua","family":"Feinberg","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emil Eik","family":"Nielsen","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janette","family":"Greenhalgh","sequence":"additional","affiliation":[{"name":"Liverpool Reviews and Implementation Group; University of Liverpool; Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juliet","family":"Hounsome","sequence":"additional","affiliation":[{"name":"Liverpool Reviews and Implementation Group; University of Liverpool; Liverpool UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naqash J","family":"Sethi","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanam","family":"Safi","sequence":"additional","affiliation":[{"name":"Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Gluud","sequence":"additional","affiliation":[{"name":"Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janus C","family":"Jakobsen","sequence":"additional","affiliation":[{"name":"Cochrane Hepato-Biliary Group, Copenhagen Trial Unit, Centre for Clinical Intervention Research; The Capital Region of Denmark, Rigshospitalet, Copenhagen University Hospital; Copenhagen Denmark"},{"name":"Department of Cardiology; Holbaek Hospital; Holbaek Denmark"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,8,23]]},"reference":[{"issue":"2","key":"10.1002\/14651858.CD012481.pub2-BIB0001|cit1","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.ijcard.2014.05.029","article-title":"The MI SYNTAX score for risk stratification in patients undergoing primary percutaneous coronary intervention for treatment of acute myocardial infarction: a substudy of the COMFORTABLE AMI trial","volume":"175","author":"Magro","year":"2014","journal-title":"International Journal of Cardiology"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0002|cit2","first-page":"35","article-title":"Long-term clinical outcomes of biolimus-eluting stents with biodegradable versus bare-metal stents in patients with acute STEMI: 5 year results of the randomized COMFORTABLE AMI trial","volume":"37","author":"Raber","year":"2016","journal-title":"European Heart Journal"},{"issue":"12","key":"10.1002\/14651858.CD012481.pub2-BIB0003|cit3","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.4244\/EIJV7I12A224","article-title":"Comparison of biolimus eluted from an erodible stent coating with bare metal stents in acute ST-elevation myocardial infarction (COMFORTABLE AMI trial): rationale and design","volume":"7","author":"Raber","year":"2012","journal-title":"EuroIntervention"},{"issue":"3","key":"10.1002\/14651858.CD012481.pub2-BIB0004|cit4","first-page":"355","article-title":"Biolimus-eluting stents with biodegradable polymer versus bare-metal stents in acute myocardial infarction: two-year clinical results of the COMFORTABLE AMI trial","volume":"7","author":"Raber","year":"2014","journal-title":"Circulation: Cardiovascular Interventions"},{"issue":"8","key":"10.1002\/14651858.CD012481.pub2-BIB0005|cit5","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1001\/jama.2012.10065","article-title":"Effect of biolimus-eluting stents with biodegradable polymer vs bare-metal stents on cardiovascular events among patients with acute myocardial infarction: The COMFORTABLE AMI randomized trial","volume":"308","author":"Raber","year":"2012","journal-title":"JAMA"},{"issue":"2","key":"10.1002\/14651858.CD012481.pub2-BIB0006|cit6","first-page":"12","article-title":"Comparison of the mid-term outcome between drug-eluting stent and bare metal stent implantation in patients undergoing primary PCI in Rajaie Heart Center January 2012 - April 2013","volume":"15","author":"Darkahian","year":"2014","journal-title":"Iranian Heart Journal"},{"issue":"Suppl N","key":"10.1002\/14651858.CD012481.pub2-BIB0007|cit7","first-page":"N25","article-title":"Results of the drug-eluting balloon in acute STEMI (DEB-AMI) trial: a multicenter randomised comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus DES in primary PCI with 6-month angiographic, intravascular, functional and 12-month clinical outcomes","volume":"8","author":"Belkacemi","year":"2012","journal-title":"EuroIntervention"},{"issue":"25","key":"10.1002\/14651858.CD012481.pub2-BIB0008|cit8","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1016\/j.jacc.2012.02.027","article-title":"First results of the DEB-AMI (drug eluting balloon in acute ST-segment elevation myocardial infarction) trial: a multicenter randomized comparison of drug-eluting balloon plus bare-metal stent versus bare-metal stent versus drug-eluting stent in primary percutaneous coronary intervention with 6-month angiographic, intravascular, functional, and clinical outcomes","volume":"59","author":"Belkacemi","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD012481.pub2-BIB0009|cit9","first-page":"313","article-title":"Comparison of drug-eluting and bare-metal stents for primary percutaneous coronary intervention with or without abciximab in ST-segment elevation myocardial infarction: DEBATER: the Eindhoven reperfusion study","volume":"5","author":"Wijnbergen","year":"2012","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"5","key":"10.1002\/14651858.CD012481.pub2-BIB0010|cit10","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/MCA.0000000000000118","article-title":"Long-term comparison of sirolimus-eluting and bare-metal stents in ST-segment elevation myocardial infarction","volume":"25","author":"Wijnbergen","year":"2014","journal-title":"Coronary Artery Disease"},{"issue":"6","key":"10.1002\/14651858.CD012481.pub2-BIB0011|cit11","first-page":"548","article-title":"Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction)","volume":"6","author":"Holmvang","year":"2013","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"Suppl H","key":"10.1002\/14651858.CD012481.pub2-BIB0012|cit12","first-page":"H132","article-title":"Long-term outcome after drug-eluting versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the DEDICATION trial","volume":"6","author":"Kaltoft","year":"2010","journal-title":"EuroIntervention"},{"issue":"8","key":"10.1002\/14651858.CD012481.pub2-BIB0013|cit13","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.jacc.2010.05.009","article-title":"Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 3-year follow-up of the randomized DEDICATION (Drug Elution and Distal Protection in Acute Myocardial Infarction) trial","volume":"56","author":"Kaltoft","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD012481.pub2-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1161\/CIRCULATIONAHA.107.758698","article-title":"Drug-eluting versus bare metal stents in patients with ST-segment-elevation myocardial infarction - eight-month follow-up in the drug elution and distal protection in acute myocardial infarction (DEDICATION) trial","volume":"118","author":"Kelbaek","year":"2008","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0015|cit15","doi-asserted-by":"crossref","first-page":"E141","DOI":"10.1016\/S0735-1097(12)60142-9","article-title":"Serial grey-scale and radiofrequency intravascular assessment of plaque modification and vessel geometry at proximal and distal edges of bare-metal and drug-eluting stents","volume":"1","author":"De Ribamar Costa","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"issue":"1 Suppl","key":"10.1002\/14651858.CD012481.pub2-BIB0016|cit16","first-page":"206","article-title":"Drug eluting versus bare metal stents in acute ST elevation myocardial infarction (DEVINE) - a randomised control trial","volume":"28","author":"Pitt","year":"2007","journal-title":"European Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD012481.pub2-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"164.e1","DOI":"10.1016\/j.ahj.2007.04.007","article-title":"Sirolimus-eluting stents compared with standard stents in the treatment of patients with primary angioplasty","volume":"154","author":"D\u00edaz de la Llera","year":"2007","journal-title":"American Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD012481.pub2-BIB0018|cit18","doi-asserted-by":"crossref","first-page":"e000455","DOI":"10.1136\/openhrt-2016-000455","article-title":"Randomised comparison of drug-eluting versus bare-metal stenting in patients with non-ST elevation myocardial infarction","volume":"3","author":"Remkes","year":"2016","journal-title":"Open Heart"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0019|cit19","first-page":"175","article-title":"Impact of everolimus-eluting stents on stent thrombosis as compared to conventional bare metal stents in patients with ST-segment elevation myocardial infarction. Insights from the EXAMINATION trial","volume":"33","author":"Brugaletta","year":"2012","journal-title":"European Heart Journal"},{"issue":"9852","key":"10.1002\/14651858.CD012481.pub2-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1016\/S0140-6736(12)61223-9","article-title":"Everolimus-eluting stent versus bare-metal stent in ST-segment elevation myocardial infarction (EXAMINATION): 1 year results of a randomised controlled trial","volume":"380","author":"Sabate","year":"2012","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD012481.pub2-BIB0021|cit21","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4244\/EIJV7I8A154","article-title":"Rationale and design of the EXAMINATION trial: a randomised comparison between everolimus-eluting stents and cobalt-chromium bare-metal stents in ST-elevation myocardial infarction","volume":"7","author":"Sabate","year":"2011","journal-title":"EuroIntervention"},{"issue":"10","key":"10.1002\/14651858.CD012481.pub2-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1097\/00029330-200705020-00002","article-title":"Firebird sirolimus eluting stent versus bare mental stent in patients with ST-segment elevation myocardial infarction","volume":"120","author":"Gao","year":"2007","journal-title":"Chinese Medical Journal"},{"issue":"4","key":"10.1002\/14651858.CD012481.pub2-BIB0023|cit23","first-page":"297","article-title":"Role of the paclitaxel-eluting stent and tirofiban in patients with ST-elevation myocardial infarction undergoing postfibrinolysis angioplasty: the GRACIA-3 randomized clinical trial","volume":"3","author":"Sanchez","year":"2010","journal-title":"Circulation: Cardiovascular Interventions"},{"issue":"Meeting abstrac","key":"10.1002\/14651858.CD012481.pub2-BIB0024|cit24","first-page":"78M","article-title":"Randomised comparison of a paclitaxel-eluting and a bare metal stent in STEMI-PCI","volume":"98","author":"Tierala","year":"2006","journal-title":"American Journal of Cardiology - TCT abstracts"},{"issue":"1","key":"10.1002\/14651858.CD012481.pub2-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2008.02.008","article-title":"The Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial: study design and rationale","volume":"156","author":"Mehran","year":"2008","journal-title":"American Heart Journal"},{"issue":"19","key":"10.1002\/14651858.CD012481.pub2-BIB0026|cit26","doi-asserted-by":"publisher","first-page":"1946","DOI":"10.1056\/NEJMoa0810116","article-title":"Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction","volume":"360","author":"Stone","year":"2009","journal-title":"New England Journal of Medicine"},{"issue":"19","key":"10.1002\/14651858.CD012481.pub2-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.jacc.2010.08.608","article-title":"Selection criteria for drug-eluting versus bare-metal stents and the impact of routine angiographic follow-up: 2-year insights from the HORIZONS-AMI (Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction) trial","volume":"56","author":"Stone","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"issue":"9784","key":"10.1002\/14651858.CD012481.pub2-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1016\/S0140-6736(11)60764-2","article-title":"Heparin plus a glycoprotein IIb\/IIIa inhibitor versus bivalirudin monotherapy and paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction (HORIZONS-AMI): final 3-year results from a multicentre, randomised controlled trial","volume":"377","author":"Stone","year":"2011","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD012481.pub2-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"979.e1-8","DOI":"10.1016\/j.ahj.2007.03.032","article-title":"Randomized comparison of dexamethasone-eluting stents with bare metal stent implantation in patients with acute coronary syndrome: serial angiographic and sonographic analysis","volume":"153","author":"K\u00f6nig","year":"2007","journal-title":"American Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD012481.pub2-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.amjcard.2010.02.005","article-title":"Three-year outcome of sirolimus-eluting versus bare-metal stents for the treatment of ST-segment elevation myocardial infarction (from the MISSION! Intervention Study)","volume":"106","author":"Atary","year":"2010","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0031|cit31","first-page":"654","article-title":"5-year outcomes of the MISSION intervention study: a randomized comparison of sirolimus-eluting to bare-metal stent implantation in patients with STEMI","volume":"32","author":"Boden","year":"2011","journal-title":"European Heart Journal"},{"issue":"9","key":"10.1002\/14651858.CD012481.pub2-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.4244\/EIJV7I9A164","article-title":"Five-year clinical follow-up from the MISSION! Intervention Study: sirolimus-eluting stent versus bare metal stent implantation in patients with ST-segment elevation myocardial infarction, a randomised controlled trial","volume":"7","author":"Boden","year":"2012","journal-title":"EuroIntervention"},{"issue":"6","key":"10.1002\/14651858.CD012481.pub2-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jacc.2007.09.056","article-title":"Sirolimus-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: 9-month angiographic and intravascular ultrasound results and 12-month clinical outcome results from the MISSION! intervention study","volume":"51","author":"Hoeven","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD012481.pub2-BIB0034|cit34","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ijcard.2011.07.106","article-title":"Three-year follow-up of the MULTIcentre evaluation of Single high-dose Bolus TiRofiban versus Abciximab with Sirolimus-eluting STEnt or Bare-Metal Stent in Acute Myocardial Infarction StudY (MULTISTRATEGY)","volume":"165","author":"Valgimigli","year":"2013","journal-title":"International Journal of Cardiology"},{"issue":"15","key":"10.1002\/14651858.CD012481.pub2-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1001\/jama.299.15.joc80026","article-title":"Comparison of angioplasty with infusion of tirofiban or abciximab and with implantation of sirolimus-eluting or uncoated stents. The MULTISTRATEGY Randomized Trial","volume":"299","author":"Valgimigli","year":"2008","journal-title":"JAMA"},{"issue":"6","key":"10.1002\/14651858.CD012481.pub2-BIB0036|cit36","first-page":"680","article-title":"Strut coverage and vessel wall response to zotarolimus-eluting and bare-metal stents implanted in patients with ST-segment elevation myocardial infarction: the OCTAMI (Optical Coherence Tomography in Acute Myocardial Infarction) Study","volume":"3","author":"Guagliumi","year":"2010","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"6","key":"10.1002\/14651858.CD012481.pub2-BIB0037|cit37","first-page":"515","article-title":"The PASEO (paclitaxel- or sirolimus-eluting stent versus bare metal stent in primary angioplasty) randomized trial","volume":"2","author":"Di Lorenzo","year":"2009","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"4","key":"10.1002\/14651858.CD012481.pub2-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"e43","DOI":"10.1016\/j.ahj.2009.03.016","article-title":"Benefits of drug-eluting stents as compared to bare metal stent in ST-segment elevation myocardial infarction: four year results of the paclitaxel or sirolimus-eluting stent vs bare metal stent in primary angioplasty (PASEO) randomized trial","volume":"158","author":"Di Lorenzo","year":"2009","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4244\/EIJV4I1A12","article-title":"Two year follow up after primary PCI with a paclitaxel-eluting stent versus a bare-metal stent for acute ST-elevation myocardial infarction (the PASSION trial): a follow-up study","volume":"4","author":"Dirksen","year":"2009","journal-title":"EuroIntervention"},{"issue":"11","key":"10.1002\/14651858.CD012481.pub2-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1056\/NEJMoa062598","article-title":"Paclitaxel-eluting versus uncoated stents in primary percutaneous coronary intervention","volume":"355","author":"Laarman","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012481.pub2-BIB0041|cit41","first-page":"24","article-title":"5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial","volume":"4","author":"Vink","year":"2011","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"4","key":"10.1002\/14651858.CD012481.pub2-BIB0042|cit42","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1111\/j.1540-8183.2007.00270.x","article-title":"Single-center randomized evaluation of paclitaxel-eluting versus conventional stent in acute myocardial infarction (SELECTION)","volume":"20","author":"Chechi","year":"2007","journal-title":"Journal of Interventional Cardiology"},{"issue":"19","key":"10.1002\/14651858.CD012481.pub2-BIB0043|cit43","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1016\/j.jacc.2007.01.081","article-title":"Randomized trial of sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction (SESAMI)","volume":"49","author":"Menichelli","year":"2007","journal-title":"Journal of the American College of Cardiology"},{"issue":"Suppl 1","key":"10.1002\/14651858.CD012481.pub2-BIB0044|cit44","first-page":"4S","article-title":"Long-term outcome of sirolimus-eluting versus bare-metal stent in the setting of acute myocardial infarction: 5-year results of the SESAMI trial","volume":"12","author":"Musto","year":"2011","journal-title":"Giornale Italiano di Cardiologia"},{"issue":"8","key":"10.1002\/14651858.CD012481.pub2-BIB0045|cit45","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jacc.2009.09.046","article-title":"Maintenance of long-term clinical benefit with sirolimus-eluting stents in patients with ST-segment elevation myocardial infarction: 3-year results of the SESAMI (sirolimus-eluting stent versus bare-metal stent in acute myocardial infarction) trial","volume":"55","author":"Violini","year":"2010","journal-title":"Journal of the American College of Cardiology"},{"issue":"8","key":"10.1002\/14651858.CD012481.pub2-BIB0046|cit46","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1002\/clc.20235","article-title":"In-stent restenosis in bare metal stents versus sirolimus-eluting stents after primary coronary intervention for acute myocardial infarction and subsequent transcoronary transplantation of autologous stem cells","volume":"31","author":"Steinwender","year":"2008","journal-title":"Clinical Cardiology"},{"issue":"3","key":"10.1002\/14651858.CD012481.pub2-BIB0047|cit47","first-page":"348","article-title":"Comparison of stent graft, sirolimus stent, and bare metal stent implanted in patients with acute coronary syndrome: clinical and angiographic follow up","volume":"48","author":"Strozzi","year":"2007","journal-title":"Croatian Medical Journal"},{"issue":"11","key":"10.1002\/14651858.CD012481.pub2-BIB0048|cit48","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1056\/NEJMoa062006","article-title":"Sirolimus-eluting versus uncoated stents in acute myocardial infarction","volume":"355","author":"Spaulding","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012481.pub2-BIB0049|cit49","first-page":"14","article-title":"Four-year follow-up of TYPHOON (trial to assess the use of the CYPHer sirolimus-eluting coronary stent in acute myocardial infarction treated with BallOON angioplasty)","volume":"4","author":"Spaulding","year":"2011","journal-title":"JACC: Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0050|cit50","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1056\/NEJMoa062437","article-title":"Bivalirudin for patients with acute coronary syndromes","volume":"355","author":"Stone","year":"2006","journal-title":"New England Journal of Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012481.pub2-BIB0051|cit51","first-page":"300","article-title":"5-year follow-up of polytetrafluoroethylene-covered stents compared with bare-metal stents in aortocoronary saphenous vein grafts: the randomized BARRICADE (barrier approach to restenosis: restrict intima to curtail adverse events) trial","volume":"4","author":"Stone","year":"2012","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"20, Suppl B","key":"10.1002\/14651858.CD012481.pub2-BIB0052|cit52","doi-asserted-by":"crossref","first-page":"B32","DOI":"10.1016\/j.jacc.2011.10.122","article-title":"Arterial response to sirolimus eluting stents with bioabsorbable polymer: First IVUS Report from the DESSOLVE-I FIM Trial","volume":"58","author":"Sakamoto","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0053|cit53","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1002\/ccd.20833","article-title":"Improved survival with drug-eluting stent implantation in comparison with bare metal stent in patients with severe left ventricular dysfunction","volume":"68","author":"Gioia","year":"2006","journal-title":"Catheterization & Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0054|cit54","first-page":"577","article-title":"Clinical outcomes following percutaneous coronary intervention with drug-eluting vs. bare-metal stents in dialysis patients","volume":"18","author":"Halkin","year":"2006","journal-title":"Journal of Invasive Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD012481.pub2-BIB0055|cit55","doi-asserted-by":"crossref","first-page":"887.e1","DOI":"10.1016\/j.ahj.2006.05.011","article-title":"The favorable clinical and angiographic outcomes of a high-dose dexamethasone-eluting stent: randomized controlled prospective study","volume":"152","author":"Han","year":"2006","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0056|cit56","doi-asserted-by":"crossref","first-page":"E1699","DOI":"10.1016\/S0735-1097(11)61699-9","article-title":"The favorable long term clinical outcomes of a high-dose dexamethasone-eluting stent: randomized controlled prospective study","volume":"1","author":"Park","year":"2011","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0057|cit57","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1093\/eurheartj\/ehi405","article-title":"Prevention of restenosis by a novel drug-eluting stent system with a dose-adjustable, polymer-free, on-site stent coating","volume":"26","author":"Hausleiter","year":"2005","journal-title":"European Heart Journal"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0058|cit58","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.amjcard.2007.06.021","article-title":"Impact of the metabolic syndrome on angiographic and clinical events after coronary intervention using bare-metal or sirolimus-eluting stents","volume":"100","author":"Hoffmann","year":"2007","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0059|cit59","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.ijcard.2014.12.151","article-title":"High incidence of coronary spasm after percutaneous coronary interventions: comparison between new generation drug-eluting stent and bare-metal stent","volume":"182","author":"Hokimoto","year":"2015","journal-title":"International Journal of Cardiology"},{"issue":"7","key":"10.1002\/14651858.CD012481.pub2-BIB0060|cit60","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1253\/circj.CJ-12-0078","article-title":"Percutaneous coronary intervention with bare metal stent vs. drug-eluting stent in hemodialysis patients","volume":"767","author":"Ishii","year":"2012","journal-title":"Circulation Journal"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0061|cit61","first-page":"301","article-title":"Circulating endothelial progenitor cells are inversely correlated with in-stent restenosis in patients with non-ST-segment elevation acute coronary syndromes treated with EPC-capture stents (JACK-EPC trial)","volume":"61","author":"Wojakowski","year":"2013","journal-title":"Minerva Cardioangiologica"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0062|cit62","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ccd.20586","article-title":"Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions","volume":"67","author":"Lee","year":"2006","journal-title":"Catheterization & Cardiovascular Interventions"},{"issue":"12","key":"10.1002\/14651858.CD012481.pub2-BIB0063|cit63","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1161\/01.CIR.102.12.1364","article-title":"Randomized comparison of GR-II stent and Palmaz-Schatz stent for elective treatment of coronary stenoses","volume":"102","author":"Lansky","year":"2000","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0064|cit64","first-page":"303","article-title":"A three-dimensional intravascular ultrasound comparison between the new zotarolimus-eluting stent (ZoMaxx) and the non-drug-eluting TriMaxx stent","volume":"19","author":"Lasave","year":"2007","journal-title":"Journal of Invasive Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD012481.pub2-BIB0065|cit65","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1002\/ccd.24677","article-title":"Rationale and design of the MGuard for acute ST elevation reperfusion MASTER trial","volume":"82","author":"Abizaid","year":"2013","journal-title":"Catheterization & Cardiovascular Interventions"},{"issue":"19","key":"10.1002\/14651858.CD012481.pub2-BIB0066|cit66","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/j.jacc.2012.09.004","article-title":"Prospective, randomized, multicenter evaluation of a polyethylene terephthalate micronet mesh-covered stent (MGuard) in ST-segment elevation myocardial infarction: The MASTER Trial","volume":"60","author":"Stone","year":"2012","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0067|cit67","doi-asserted-by":"crossref","first-page":"56M","DOI":"10.1016\/j.amjcard.2007.08.023","article-title":"Four-year clinical follow-up after implantation of the Endeavor zotarolimus-eluting stent: ENDEAVOR I, the first-in-human study","volume":"100","author":"Meredith","year":"2007","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0068|cit68","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.ahj.2006.07.025","article-title":"Angioscopic evaluation of neointima coverage: sirolimus drug-eluting stent versus bare metal stent","volume":"152","author":"Oyabu","year":"2006","journal-title":"American Heart Journal"},{"issue":"6 (S1)","key":"10.1002\/14651858.CD012481.pub2-BIB0069|cit69","first-page":"H1-4","article-title":"Paclitaxil-eluting stents for cytostatic prevention of restenosis: patency study follow-up","volume":"1","author":"Heldman","year":"2002","journal-title":"American Journal of Cardiology"},{"issue":"2","key":"10.1002\/14651858.CD012481.pub2-BIB0070|cit70","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.jacc.2005.03.069","article-title":"The effect of variable dose and release kinetics on neointimal hyperplasia using a novel paclitaxel-eluting stent platform: the Paclitaxel In-Stent Controlled Elution Study (PISCES)","volume":"46","author":"Serruys","year":"2005","journal-title":"Journal of the American College of Cardiology"},{"issue":"17","key":"10.1002\/14651858.CD012481.pub2-BIB0071|cit71","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1001\/jama.293.17.2109","article-title":"Tirofiban and sirolimus-eluting stent vs abciximab and bare-metal stent for acute myocardial infarction: a randomized trial","volume":"293","author":"Valgimigli","year":"2005","journal-title":"JAMA"},{"issue":"8","key":"10.1002\/14651858.CD012481.pub2-BIB0072|cit72","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1253\/circj.CJ-13-0017","article-title":"Long-term outcome of drug-eluting vs. bare-metal stents in patients with acute myocardial infarction. Subgroup analysis of the Nagoya Acute Myocardial Infarction Study (NAMIS)","volume":"77","author":"Suzuki","year":"2013","journal-title":"Circulation Journal"},{"issue":"3","key":"10.1002\/14651858.CD012481.pub2-BIB0073|cit73","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/ccd.10656","article-title":"Silicon carbide-coated stents in patients with acute coronary syndrome","volume":"60","author":"Hamm","year":"2003","journal-title":"Catheterization & Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0074|cit74","first-page":"284","article-title":"Heparin-coated stent implantation in patients with unstable angina pectoris: a randomized trial","volume":"19","author":"Turan","year":"1998","journal-title":"European Heart Journal"},{"issue":"7","key":"10.1002\/14651858.CD012481.pub2-BIB0075|cit75","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1002\/ccd.24909","article-title":"Clinical, angiographic, and intravascular ultrasound results of the VestSaync II trial","volume":"84","author":"Oliveira","year":"2014","journal-title":"Catheterization & Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0076|cit76","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1161\/CIRCULATIONAHA.104.486647","article-title":"Randomized comparison of a titanium-nitride-oxide-coated stent with a stainless steel stent for coronary revascularization - The TiNOX trial","volume":"111","author":"Windecker","year":"2005","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0077|cit77","doi-asserted-by":"crossref","first-page":"B78","DOI":"10.1016\/j.jacc.2013.08.973","article-title":"Low event rates at long-term follow-up in the randomized myocardial infarction XAMI trial comparing first and second generation drug eluting stents","volume":"1","author":"Hofma","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0078|cit78","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S0140-6736(05)67221-2","article-title":"Incremental cost-effectiveness of drug-eluting stents compared with a third-generation bare-metal stent in a real world setting: Randomised Basel Stent Kosten Effektivit\u00e4ts Trial (BASKET)","volume":"366","author":"Kaiser","year":"2005","journal-title":"Lancet"},{"issue":"24","key":"10.1002\/14651858.CD012481.pub2-BIB0079|cit79","doi-asserted-by":"publisher","first-page":"2310","DOI":"10.1056\/NEJMoa1009406","article-title":"Drug-eluting versus bare-metal stents in large coronary arteries","volume":"363","author":"Kaiser","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012481.pub2-BIB0080|cit80","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1161\/CIRCULATIONAHA.114.013520","article-title":"Long-term efficacy and safety of biodegradable-polymer biolimus-eluting stents: main results of the Basel Stent Kosten-Effektivit\u00e4ts Trial-PROspective Validation Examination II (BASKET-PROVE II), a randomized, controlled noninferiority 2-year outcome trial","volume":"131","author":"Kaiser","year":"2015","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0081|cit81","first-page":"596","article-title":"European study of Axxion and Glycocalix long-term evaluation","volume":"31","author":"Ischinger","year":"2006","journal-title":"Herz"},{"issue":"6","key":"10.1002\/14651858.CD012481.pub2-BIB0082|cit82","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.jacc.2007.03.055","article-title":"A randomized comparison of paclitaxel-eluting stents versus bare-metal stents for treatment of unprotected left main coronary artery stenosis","volume":"50","author":"Erglis","year":"2007","journal-title":"Journal of the American College of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD012481.pub2-BIB0083|cit83","doi-asserted-by":"crossref","first-page":"113-6","DOI":"10.1016\/j.amjcard.2004.08.074","article-title":"Angiographic results of the first human experience with everolimus-eluting stents for the treatment of coronary lesions (the FUTURE I trial)","volume":"95","author":"Costa","year":"2005","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0084|cit84","doi-asserted-by":"crossref","first-page":"2168-71","DOI":"10.1161\/01.CIR.0000128850.84227.FD","article-title":"Six-and twelve-month results from first human experience using everolimus-eluting stents with bioabsorbable polymer","volume":"109","author":"Grube","year":"2004","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD012481.pub2-BIB0085|cit85","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1540-8183.2004.04080.x","article-title":"Clinical experiences using everolimus-eluting stents in patients with coronary artery disease","volume":"17","author":"Storger","year":"2004","journal-title":"Journal of Interventional Cardiology"},{"issue":"7","key":"10.1002\/14651858.CD012481.pub2-BIB0086|cit86","doi-asserted-by":"crossref","first-page":"552-6","DOI":"10.1097\/00029330-200704010-00005","article-title":"Midterm outcomes of prospective, randomized, single-center study of the Janus tacrolimus-eluting stent for treatment of native coronary artery lesions","volume":"120","author":"Han","year":"2007","journal-title":"Chinese Medical Journal"},{"issue":"6A","key":"10.1002\/14651858.CD012481.pub2-BIB0087|cit87","first-page":"218E","article-title":"Randomized study to evaluate sirolimus-eluting stents implanted at coronary small vessel lesions","volume":"94","author":"Li","year":"2004","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0088|cit88","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1056\/NEJMoa1607991","article-title":"Drug-eluting or bare-metal stents for coronary artery disease","volume":"375","author":"B\u00f8naa","year":"2016","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012481.pub2-BIB0089|cit89","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/j.ahj.2010.07.034","article-title":"Randomized comparison of 6- versus 24-month clopidogrel therapy after balancing anti-intimal hyperplasia stent potency in all-comer patients undergoing percutaneous coronary intervention: Design and rationale for the PROlonging Dual-antiplatelet treatment after Grading stent-induced Intimal hyperplasia study (PRODIGY)","volume":"160","author":"Valgimigli","year":"2010","journal-title":"American Heart Journal"},{"issue":"1","key":"10.1002\/14651858.CD012481.pub2-BIB0090|cit90","first-page":"20","article-title":"Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention","volume":"7","author":"Valgimigli","year":"2014","journal-title":"JACC: Cardiovascular Interventions"},{"issue":"22","key":"10.1002\/14651858.CD012481.pub2-BIB0091|cit91","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.292.22.2727","article-title":"Sirolimus-eluting vs uncoated stents for prevention of restenosis in small coronary arteries: a randomized trial","volume":"292","author":"Ardissino","year":"2004","journal-title":"JAMA"},{"issue":"14","key":"10.1002\/14651858.CD012481.pub2-BIB0092|cit92","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1016\/j.jacc.2013.10.053","article-title":"A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians","volume":"63","author":"Belder","year":"2014","journal-title":"Journal of the American College of Cardiology"},{"issue":"5","key":"10.1002\/14651858.CD012481.pub2-BIB0093|cit93","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.ahj.2013.07.033","article-title":"Randomized comparison of zotarolimus-eluting Endeavor Sprint versus bare-metal stent implantation in uncertain drug-eluting stent candidates: rationale, design, and characterization of the patient population for the Zotarolimus-Eluting Endeavor Sprint Stent in Uncertain DES Candidates study","volume":"166","author":"Valgimigli","year":"2013","journal-title":"American Heart Journal"},{"issue":"8","key":"10.1002\/14651858.CD012481.pub2-BIB0094|cit94","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.jacc.2014.11.053","article-title":"Zotarolimus-eluting versus bare-metal stents in uncertain drug-eluting stent candidates","volume":"65","author":"Valgimigli","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"issue":"4","key":"10.1002\/14651858.CD012481.pub2-BIB0095|cit95","first-page":"384","article-title":"New drug-eluting stents: an overview on biodegradable and polymer-free next-generation stent systems","volume":"3","author":"Abizaid","year":"2010","journal-title":"Circulation: Cardiovascular Interventions"},{"issue":"4","key":"10.1002\/14651858.CD012481.pub2-BIB0096|cit96","doi-asserted-by":"crossref","first-page":"e78","DOI":"10.1016\/j.jacc.2012.11.019","article-title":"2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"61","author":"O'Gara","year":"2013","journal-title":"Journal of the American College of Cardiology"},{"issue":"25","key":"10.1002\/14651858.CD012481.pub2-BIB0097|cit97","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.1161\/CIR.0000000000000133","article-title":"2014 AHA\/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"130","author":"Amsterdam","year":"2014","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0098|cit98","first-page":"17","volume-title":"Cardiac Catheterization, Angiography and Intervention","author":"Baim","year":"1996"},{"issue":"21","key":"10.1002\/14651858.CD012481.pub2-BIB0099|cit99","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1161\/01.CIR.98.21.2219","article-title":"Unstable angina: an etiologic approach to management","volume":"98","author":"Braunwald","year":"1998","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0100|cit100","unstructured":"Breall JA Aroesty JM Simons M Overview of the non-acute management of unstable angina and non-ST elevation myocardial infarction www.uptodate.com\/contents\/overview-of-the-non-acute-management-of-unstable-angina-and-non-st-elevation-myocardial-infarction"},{"issue":"11","key":"10.1002\/14651858.CD012481.pub2-BIB0101|cit101","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/hrt.2008.153387","article-title":"Predicting freedom from clinical events in non-ST-elevation acute coronary syndromes: the Global Registry of Acute Coronary Events","volume":"95","author":"Brieger","year":"2009","journal-title":"Heart"},{"issue":"8","key":"10.1002\/14651858.CD012481.pub2-BIB0102|cit102","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/j.jclinepi.2007.10.007","article-title":"Trial sequential analysis reveals insufficient information size and potentially false positive results in many meta-analyses","volume":"61","author":"Brok","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"issue":"1","key":"10.1002\/14651858.CD012481.pub2-BIB0103|cit103","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1093\/ije\/dyn188","article-title":"Apparently conclusive meta-analyses may be inconclusive. Trial sequential analysis adjustment of random error risk due to repetitive testing of accumulating data in apparently conclusive neonatal meta-analyses","volume":"38","author":"Brok","year":"2009","journal-title":"International Journal of Epidemiology"},{"issue":"6","key":"10.1002\/14651858.CD012481.pub2-BIB0104|cit104","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/S0002-8703(98)70168-1","article-title":"Failed coronary stent deployment","volume":"136","author":"Cantor","year":"1998","journal-title":"American Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD012481.pub2-BIB0105|cit105","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ahj.2004.10.043","article-title":"Radial versus femoral access for emergent percutaneous coronary intervention with adjunct glycoprotein IIb\/IIIa inhibition in acute myocardial infarction - the RADIAL-AMI pilot randomized trial","volume":"150","author":"Cantor","year":"2005","journal-title":"American Heart Journal"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0106|cit106","unstructured":"Castellini G Nielsen EE Gluud C Comment on: \"Cell therapy for heart disease: Trial sequential analyses of two Cochrane reviews\" Clinical Pharmacology and Therapeutics 10.1002\/cpt.536"},{"issue":"3","key":"10.1002\/14651858.CD012481.pub2-BIB0107|cit107","doi-asserted-by":"crossref","first-page":"200","DOI":"10.7326\/0003-4819-158-3-201302050-00583","article-title":"SPIRIT 2013 Statement: Defining standard protocol items for clinical trials","volume":"158","author":"Tetzlaff","year":"2013","journal-title":"Annals of Internal Medicine"},{"issue":"7","key":"10.1002\/14651858.CD012481.pub2-BIB0108|cit108","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1021\/acs.bioconjchem.5b00192","article-title":"Polymer-free drug-eluting stents: an overview of coating strategies and comparison with polymer-coated drug-eluting stents","volume":"26","author":"Chen","year":"2015","journal-title":"Bioconjugate Chemistry"},{"issue":"25","key":"10.1002\/14651858.CD012481.pub2-BIB0109|cit109","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1161\/01.CIR.102.25.3137","article-title":"Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention","volume":"102","author":"Cooper","year":"2000","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0110|cit110","unstructured":"Trial Sequential Analysis (TSA) (www.ctu.dk\/tsa) Copenhagen Trial Unit (CTU) Centre for Clinical Intervention Research Copenhagen, Denmark 2011"},{"issue":"12","key":"10.1002\/14651858.CD012481.pub2-BIB0111|cit111","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1016\/S0735-1097(02)02597-4","article-title":"Clinical restenosis after coronary stenting: perspectives from multicenter clinical trials","volume":"40","author":"Cutlip","year":"2002","journal-title":"Journal of the American College of Cardiology"},{"issue":"17","key":"10.1002\/14651858.CD012481.pub2-BIB0112|cit112","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1161\/CIRCULATIONAHA.106.685313","article-title":"Clinical end points in coronary stent trials: a case for standardized definitions","volume":"115","author":"Cutlip","year":"2007","journal-title":"Circulation"},{"issue":"22","key":"10.1002\/14651858.CD012481.pub2-BIB0113|cit113","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1161\/01.CIR.0000019122.00032.DF","article-title":"Restenosis: repeat narrowing of a coronary artery","volume":"105","author":"Dangas","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1002\/14651858.CD012481.pub2-BIB0114|cit114","first-page":"405","article-title":"Sirolimus eluting stent in the treatment of atherosclerosis coronary artery disease","volume":"50","author":"Degertekin","year":"2002","journal-title":"Minerva Cardioangiologica"},{"issue":"8","key":"10.1002\/14651858.CD012481.pub2-BIB0115|cit115","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1001\/archinternmed.2012.758","article-title":"Drug-eluting vs bare-metal stents in primary angioplasty: a pooled patient-level meta-analysis of randomized trials","volume":"172","author":"De Luca","year":"2012","journal-title":"Archives of Internal Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012481.pub2-BIB0116|cit116","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/sim.4780060325","article-title":"Methods for combining randomized clinical trials: strengths and limitations","volume":"6","author":"Demets","year":"1987","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012481.pub2-BIB0117|cit117","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Controlled Clinical Trials"},{"issue":"9","key":"10.1002\/14651858.CD012481.pub2-BIB0118|cit118","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/0002-9149(86)90340-1","article-title":"Morphology of the coronary arteries after combined thrombolysis and percutaneous transluminal coronary angioplasty for acute myocardial infarction","volume":"58","author":"D\u00fcber","year":"1986","journal-title":"American Journal of Cardiology"},{"issue":"1","key":"10.1002\/14651858.CD012481.pub2-BIB0119|cit119","doi-asserted-by":"crossref","first-page":"e002155","DOI":"10.1136\/bmjopen-2012-002155","article-title":"Differences between acute myocardial infarction and unstable angina: a longitudinal cohort study reporting findings from the Register of Information and Knowledge about Swedish Heart Intensive Care Admissions (RIKS-HIA)","volume":"3","author":"Dudas","year":"2013","journal-title":"BMJ Open"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0120|cit120","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"issue":"23","key":"10.1002\/14651858.CD012481.pub2-BIB0121|cit121","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1056\/NEJM199812033392304","article-title":"Coronary-artery stenting compared with balloon angioplasty for restenosis after initial balloon angioplasty. Restenosis Stent Study Group","volume":"339","author":"Erbel","year":"1998","journal-title":"New England Journal of Medicine"},{"issue":"8","key":"10.1002\/14651858.CD012481.pub2-BIB0122|cit122","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1161\/CIRCULATIONAHA.105.591206","article-title":"Randomized, double-blind, multicenter study of the Endeavor zotarolimus-eluting phosphorylcholine-encapsulated stent for treatment of native coronary artery lesions: clinical and angiographic results of the ENDEAVOR II trial","volume":"114","author":"Fajadet","year":"2006","journal-title":"Circulation"},{"issue":"9867","key":"10.1002\/14651858.CD012481.pub2-BIB0123|cit123","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/S0140-6736(13)60108-7","article-title":"Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II","volume":"381","author":"Farooq","year":"2013","journal-title":"Lancet"},{"issue":"8","key":"10.1002\/14651858.CD012481.pub2-BIB0124|cit124","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","article-title":"A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators","volume":"331","author":"Fischman","year":"1994","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0125|cit125","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejim.2016.03.020","article-title":"Evidence-based clinical practice: overview of threats to the validity of evidence and how to minimise them","volume":"32","author":"Garattini","year":"2016","journal-title":"European Journal of Internal Medicine"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0126|cit126","doi-asserted-by":"crossref","unstructured":"Gensini GG A more meaningful scoring system for determining the severity of coronary heart disease American Journal of Cardiology 1983 51 3 606 6823874","DOI":"10.1016\/S0002-9149(83)80105-2"},{"issue":"6","key":"10.1002\/14651858.CD012481.pub2-BIB0127|cit127","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/aje\/kwj069","article-title":"Bias in clinical intervention research","volume":"163","author":"Gluud","year":"2006","journal-title":"American Journal of Epidemiology"},{"issue":"5","key":"10.1002\/14651858.CD012481.pub2-BIB0128|cit128","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004587.pub3","article-title":"Drug-eluting stents versus bare metal stents for angina or acute coronary syndromes","author":"Greenhalgh","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"8058","key":"10.1002\/14651858.CD012481.pub2-BIB0129|cit129","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S0140-6736(78)90500-7","article-title":"Transluminal dilatation of coronary-artery stenosis","volume":"1","author":"Gr\u00fcntzig","year":"1978","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD012481.pub2-BIB0130|cit130","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1056\/NEJM197907123010201","article-title":"Nonoperative dilatation of coronary-artery stenosis: percutaneous transluminal coronary angioplasty","volume":"301","author":"Gr\u00fcntzig","year":"1979","journal-title":"New England Journal of Medicine"},{"issue":"18","key":"10.1002\/14651858.CD012481.pub2-BIB0131|cit131","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1016\/S0195-668X(03)00433-0","article-title":"International differences in in-hospital revascularization and outcomes following acute myocardial infarction","volume":"24","author":"Gupta","year":"2003","journal-title":"European Heart Journal"},{"issue":"7650","key":"10.1002\/14651858.CD012481.pub2-BIB0132|cit132","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"issue":"1","key":"10.1002\/14651858.CD012481.pub2-BIB0133|cit133","doi-asserted-by":"crossref","first-page":"115","DOI":"10.4244\/EIJV5I1A18","article-title":"Choice of arterial access site and outcomes in patients with acute coronary syndromes managed with an early invasive strategy: the ACUITY trial","volume":"5","author":"Hamon","year":"2009","journal-title":"EuroIntervention"},{"issue":"20","key":"10.1002\/14651858.CD012481.pub2-BIB0134|cit134","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Statistics in Medicine"},{"issue":"9869","key":"10.1002\/14651858.CD012481.pub2-BIB0135|cit135","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(12)61765-6","article-title":"Safety and performance of the drug-eluting absorbable metal scaffold (DREAMS) in patients with de-novo coronary lesions: 12 month results of the prospective, multicentre, first-in-man BIOSOLVE-I trial","volume":"381","author":"Haude","year":"2013","journal-title":"Lancet"},{"issue":"10013","key":"10.1002\/14651858.CD012481.pub2-BIB0136|cit136","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(15)00447-X","article-title":"Safety and performance of the second-generation drug-eluting absorbable metal scaffold in patients with de-novo coronary artery lesions (BIOSOLVE-II): 6 month results of a prospective, multicentre, non-randomised, first-in-man trial","volume":"387","author":"Haude","year":"2016","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0137|cit137","unstructured":"Hicks KA Hung JHM Mahaffey KW Mehran R Nissen SE Stockbridge NL Standardized definitions for end point events in cardiovascular trials www.clinpage.com\/images\/uploads\/endpoint-defs_11-16-2010.pdf"},{"issue":"11","key":"10.1002\/14651858.CD012481.pub2-BIB0138|cit138","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Statistics in Medicine"},{"issue":"7414","key":"10.1002\/14651858.CD012481.pub2-BIB0139|cit139","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0140|cit140","unstructured":"Higgins JP Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"issue":"9","key":"10.1002\/14651858.CD012481.pub2-BIB0141|cit141","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/sim.4088","article-title":"Sequential methods for random-effects meta-analysis","volume":"30","author":"Higgins","year":"2011","journal-title":"Statistics in Medicine"},{"issue":"3","key":"10.1002\/14651858.CD012481.pub2-BIB0142|cit142","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD004815.pub4","article-title":"Early invasive versus conservative strategies for unstable angina and non-ST elevation myocardial infarction in the stent era","author":"Hoenig","year":"2010","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"5","key":"10.1002\/14651858.CD012481.pub2-BIB0143|cit143","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/01.CIR.0000112572.57794.22","article-title":"Analysis of 1-year clinical outcomes in the SIRIUS trial: a randomized trial of a sirolimus-eluting stent versus a standard stent in patients at high risk for coronary restenosis","volume":"109","author":"Leon","year":"2004","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0144|cit144","doi-asserted-by":"crossref","first-page":"e1119","DOI":"10.1136\/bmj.e1119","article-title":"Observer bias in randomised clinical trials with binary outcomes: systematic review of trials with both blinded and non-blinded outcome assessors","volume":"344","author":"Hrobjartsson","year":"2012","journal-title":"BMJ (Clinical Research Ed)"},{"issue":"4","key":"10.1002\/14651858.CD012481.pub2-BIB0145|cit145","doi-asserted-by":"crossref","first-page":"E201","DOI":"10.1503\/cmaj.120744","article-title":"Observer bias in randomized clinical trials with measurement scale outcomes: a systematic review of trials with both blinded and nonblinded assessors","volume":"185","author":"Hrobjartsson","year":"2013","journal-title":"CMAJ: Canadian Medical Association Journal"},{"issue":"3","key":"10.1002\/14651858.CD012481.pub2-BIB0146|cit146","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/ije\/dyt270","article-title":"Observer bias in randomized clinical trials with time-to-event outcomes: systematic review of trials with both blinded and non-blinded outcome assessors","volume":"43","author":"Hrobjartsson","year":"2014","journal-title":"International Journal of Epidemiology"},{"issue":"4","key":"10.1002\/14651858.CD012481.pub2-BIB0147|cit147","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/ije\/dyu115","article-title":"Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies","volume":"43","author":"Hrobjartsson","year":"2014","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0148|cit148","volume-title":"International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use. ICH Harmonised Tripartite Guideline. Guideline for Good Clinical Practice in CFR & ICH Guidelines","volume":"1","author":"International Conference on Harmonisation Expert Working Group (ICH-EWG)","year":"1997"},{"issue":"19","key":"10.1002\/14651858.CD012481.pub2-BIB0149|cit149","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/archinternmed.2009.313","article-title":"Adverse events in randomized trials: neglected, restricted, distorted, and silenced","volume":"169","author":"Ioannidis","year":"2009","journal-title":"Archives of Internal Medicine"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0150|cit150","unstructured":"Jackson D Turner R Power analysis for random-effects meta-analysis Research Synthesis Methods 10.1002\/jrsm.1240 28378395"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0151|cit151","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/1471-2288-14-120","article-title":"Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods","volume":"14","author":"Jakobsen","year":"2014","journal-title":"BMC Medical Research Methodology"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0152|cit152","doi-asserted-by":"crossref","unstructured":"Jakobsen JC Wetterslev J Lange T Gluud C Viewpoint: taking into account risks of random errors when analysing multiple outcomes in systematic reviews The Cochrane Database of Systematic Reviews 2016 3 ED000111 10.1002\/14651858.ED000111","DOI":"10.1002\/14651858.ED000111"},{"issue":"10","key":"10.1002\/14651858.CD012481.pub2-BIB0153|cit153","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1056\/NEJMoa067484","article-title":"Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents","volume":"356","author":"Kastrati","year":"2007","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0154|cit154","doi-asserted-by":"crossref","unstructured":"Keus F Wetterslev J Gluud C van Laarhoven CJ Evidence at a glance: error matrix approach for overviewing available evidence BMC Medical Research Methodology 2010 10 90","DOI":"10.1186\/1471-2288-10-90"},{"issue":"7","key":"10.1002\/14651858.CD012481.pub2-BIB0155|cit155","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/j.jacc.2007.10.034","article-title":"The problem with composite end points in cardiovascular studies: the story of major adverse cardiac events and percutaneous coronary intervention","volume":"51","author":"Kip","year":"2008","journal-title":"Journal of the American College of Cardiology"},{"issue":"11","key":"10.1002\/14651858.CD012481.pub2-BIB0156|cit156","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-135-11-200112040-00010","article-title":"Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses","volume":"135","author":"Kjaergard","year":"2001","journal-title":"Annals of Internal Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012481.pub2-BIB0157|cit157","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/ccd.20498","article-title":"Drug-eluting stenting is superior to bare metal stenting in saphenous vein grafts","volume":"66","author":"Lee","year":"2005","journal-title":"Catheterization & Cardiovascular Interventions"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0158|cit158","unstructured":"Lefebvre C Manheimer E Glanville J Chapter 6: Searching for studies. In: Higgins JP, Green S, editor(s). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011 Available from handbook.cochrane.org"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0159|cit159","unstructured":"Levin T Aroesty JM Stable ischemic heart disease: indications for revascularization www.uptodate.com\/contents\/stable-ischemic-heart-disease-indications-for-revascularization"},{"issue":"23","key":"10.1002\/14651858.CD012481.pub2-BIB0160|cit160","doi-asserted-by":"crossref","first-page":"2574","DOI":"10.1161\/CIR.0b013e31823a5596","article-title":"2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines and the Society for Cardiovascular Angiography and Interventions","volume":"124","author":"Levine","year":"2011","journal-title":"Circulation"},{"issue":"10","key":"10.1002\/14651858.CD012481.pub2-BIB0161|cit161","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/j.jacc.2015.10.005","article-title":"2015 ACC\/AHA\/SCAI focused update on primary percutaneous coronary intervention for patients with ST-elevation myocardial infarction: an update of the 2011 ACCF\/AHA\/SCAI guideline for percutaneous coronary intervention and the 2013 ACCF\/AHA guideline for the management of ST-elevation myocardial infarction","volume":"67","author":"Levine","year":"2016","journal-title":"Journal of the American College of Cardiology"},{"issue":"7","key":"10.1002\/14651858.CD012481.pub2-BIB0162|cit162","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/CIRCULATIONAHA.109.192666","article-title":"Executive summary: heart disease and stroke statistics - 2010 update: a report from the American Heart Association","volume":"121","author":"Lloyd-Jones","year":"2010","journal-title":"Circulation"},{"issue":"12","key":"10.1002\/14651858.CD012481.pub2-BIB0163|cit163","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.MR000033.pub2","article-title":"Industry sponsorship and research outcome","author":"Lundh","year":"2012","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0164|cit164","doi-asserted-by":"crossref","first-page":"j176","DOI":"10.1136\/bmj.j176","article-title":"The ties that bind","volume":"356","author":"Lundh","year":"2017","journal-title":"BMJ"},{"issue":"2","key":"10.1002\/14651858.CD012481.pub2-BIB0165|cit165","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/0735-1097(95)00473-4","article-title":"Continued benefit of coronary stenting versus balloon angioplasty: one-year clinical follow-up of Benestent trial. Benestent Study Group","volume":"27","author":"Macaya","year":"1996","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0166|cit166","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2261-7-28","article-title":"One-year health status outcomes of unstable angina versus myocardial infarction: a prospective, observational cohort study of ACS survivors","volume":"7","author":"Maddox","year":"2007","journal-title":"BMC Cardiovascular Disorders"},{"issue":"4","key":"10.1002\/14651858.CD012481.pub2-BIB0167|cit167","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/ccd.1810070408","article-title":"Treatment of unstable angina pectoris with percutaneous transluminal coronary angioplasty (PTCA)","volume":"7","author":"Meyer","year":"1981","journal-title":"Catheterization and Cardiovascular Diagnosis"},{"issue":"1","key":"10.1002\/14651858.CD012481.pub2-BIB0168|cit168","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/0002-8703(82)90540-3","article-title":"Successful treatment of acute myocardial infarction shock by combined percutaneous transluminal coronary recanalization (PTCR) and percutaneous transluminal coronary angioplasty (PTCA)","volume":"103","author":"Meyer","year":"1982","journal-title":"American Heart Journal"},{"issue":"5","key":"10.1002\/14651858.CD012481.pub2-BIB0169|cit169","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1161\/01.CIR.66.5.905","article-title":"Percutaneous transluminal coronary angioplasty immediately after intracoronary streptolysis of transmural myocardial infarction","volume":"66","author":"Meyer","year":"1982","journal-title":"Circulation"},{"issue":"5 Pt 1","key":"10.1002\/14651858.CD012481.pub2-BIB0170|cit170","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/0002-8703(83)90640-3","article-title":"Percutaneous transluminal coronary angioplasty in patients with stable and unstable angina pectoris: analysis of early and late results","volume":"106","author":"Meyer","year":"1983","journal-title":"American Heart Journal"},{"issue":"9128","key":"10.1002\/14651858.CD012481.pub2-BIB0171|cit171","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"issue":"23","key":"10.1002\/14651858.CD012481.pub2-BIB0172|cit172","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1056\/NEJMoa012843","article-title":"A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization","volume":"346","author":"Morice","year":"2002","journal-title":"New England Journal of Medicine"},{"issue":"14","key":"10.1002\/14651858.CD012481.pub2-BIB0173|cit173","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa035071","article-title":"Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery","volume":"349","author":"Moses","year":"2003","journal-title":"New England Journal of Medicine"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0174|cit174","unstructured":"NICE (National Institute for Health and Care Excellence) Drug-eluting stents for the treatment of coronary artery disease www.nice.org.uk\/guidance\/ta152?unlid=1066690929201610722145"},{"issue":"42","key":"10.1002\/14651858.CD012481.pub2-BIB0175|cit175","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1093\/eurheartj\/ehu299","article-title":"Cardiovascular disease in Europe 2014: epidemiological update","volume":"35","author":"Nichols","year":"2014","journal-title":"European Heart Journal"},{"issue":"2","key":"10.1002\/14651858.CD012481.pub2-BIB0176|cit176","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005313","article-title":"Primary stenting versus primary balloon angioplasty for treating acute myocardial infarction","author":"Nordmann","year":"2005","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"24","key":"10.1002\/14651858.CD012481.pub2-BIB0177|cit177","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1016\/j.jacc.2015.10.036","article-title":"Design of major randomized trials: part 3 of a 4-part series on statistics for clinical trials","volume":"66","author":"Pocock","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"issue":"6","key":"10.1002\/14651858.CD012481.pub2-BIB0178|cit178","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S0197-2456(97)00051-2","article-title":"Cumulating evidence from randomized trials: utilizing sequential monitoring boundaries for cumulative meta-analysis","volume":"18","author":"Pogue","year":"1997","journal-title":"Controlled Clinical Trials"},{"issue":"4","key":"10.1002\/14651858.CD012481.pub2-BIB0179|cit179","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/0002-8703(89)90617-0","article-title":"Ventricular septal and free wall rupture complicating acute myocardial infarction: experience in the Multicenter Investigation of Limitation of Infarct Size","volume":"117","author":"Pohjola-Sintonen","year":"1989","journal-title":"American Heart Journal"},{"issue":"8","key":"10.1002\/14651858.CD012481.pub2-BIB0180|cit180","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/0002-9149(88)90762-X","article-title":"Early and late assessment of stenosis geometry after coronary arterial stenting","volume":"61","author":"Puel","year":"1988","journal-title":"American Journal of Cardiology"},{"issue":"8","key":"10.1002\/14651858.CD012481.pub2-BIB0181|cit181","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jacc.2014.12.017","article-title":"Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds","volume":"65","author":"Puricel","year":"2015","journal-title":"Journal of the American College of Cardiology"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0182|cit182","unstructured":"Nordic Cochrane Centre, The Cochrane Collaboration Review Manager 5 (RevMan 5) 2014"},{"issue":"6","key":"10.1002\/14651858.CD012481.pub2-BIB0183|cit183","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1172\/JCI110941","article-title":"Prognostic value of angiographic indices of coronary artery disease from the Coronary Artery Surgery Study (CASS)","volume":"71","author":"Ringqvist","year":"1983","journal-title":"Journal of Clinical Investigation"},{"issue":"3","key":"10.1002\/14651858.CD012481.pub2-BIB0184|cit184","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/eurheartj\/ehv320","article-title":"2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: Task Force for the Management of Acute Coronary Syndromes in Patients Presenting Without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)","volume":"37","author":"Roffi","year":"2016","journal-title":"European Heart Journal"},{"issue":"4","key":"10.1002\/14651858.CD012481.pub2-BIB0185|cit185","first-page":"e25","article-title":"Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee","volume":"117","author":"Rosamond","year":"2008","journal-title":"Circulation"},{"issue":"6","key":"10.1002\/14651858.CD012481.pub2-BIB0186|cit186","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/j.amjmed.2008.12.019","article-title":"Comprehensive meta-analysis on drug-eluting stents versus bare-metal stents during extended follow-up","volume":"122","author":"Roukoz","year":"2009","journal-title":"American Journal of Medicine"},{"issue":"5","key":"10.1002\/14651858.CD012481.pub2-BIB0187|cit187","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/sim.2971","article-title":"Arcsine test for publication bias in meta-analyses with binary outcomes","volume":"27","author":"R\u00fccker","year":"2008","journal-title":"Statistics in Medicine"},{"issue":"11","key":"10.1002\/14651858.CD012481.pub2-BIB0188|cit188","first-page":"PH46","article-title":"Cardiogenic shock in acute coronary syndrome in the Spanish population","volume":"14","author":"Ruiz-Bail\u00e9n","year":"2008","journal-title":"Medical Science Monitor"},{"issue":"6","key":"10.1002\/14651858.CD012481.pub2-BIB0189|cit189","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Annals of Internal Medicine"},{"issue":"35","key":"10.1002\/14651858.CD012481.pub2-BIB0190|cit190","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta16350","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies","volume":"16","author":"Savovi\u0107","year":"2012","journal-title":"Health Technology Assessment"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0191|cit191","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1136\/bmj.e356","article-title":"25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study","volume":"344","author":"Schmidt","year":"2012","journal-title":"BMJ"},{"issue":"5","key":"10.1002\/14651858.CD012481.pub2-BIB0192|cit192","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"issue":"11","key":"10.1002\/14651858.CD012481.pub2-BIB0193|cit193","doi-asserted-by":"crossref","first-page":"726","DOI":"10.7326\/0003-4819-152-11-201006010-00232","article-title":"CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials","volume":"152","author":"Schulz","year":"2010","journal-title":"Annals of Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012481.pub2-BIB0194|cit194","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0002-9149(82)90299-5","article-title":"On the limitation of therapeutic intervention trials in ischemic heart disease: a clinican's viewpoint","volume":"49","author":"Seizer","year":"1982","journal-title":"American Journal of Cardiology"},{"issue":"8","key":"10.1002\/14651858.CD012481.pub2-BIB0195|cit195","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group","volume":"331","author":"Serruys","year":"1994","journal-title":"New England Journal of Medicine"},{"issue":"9129","key":"10.1002\/14651858.CD012481.pub2-BIB0196|cit196","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(97)11128-X","article-title":"Randomised comparison of implantation of heparin-coated stents with balloon angioplasty in selected patients with coronary artery disease (Benestent II)","volume":"352","author":"Serruys","year":"1998","journal-title":"Lancet"},{"issue":"2","key":"10.1002\/14651858.CD012481.pub2-BIB0197|cit197","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa1004130","article-title":"Comparison of zotarolimus-eluting and everolimus-eluting coronary stents","volume":"363","author":"Serruys","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"2","key":"10.1002\/14651858.CD012481.pub2-BIB0198|cit198","first-page":"219","article-title":"The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease","volume":"1","author":"Sianos","year":"2005","journal-title":"EuroIntervention"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0199|cit199","unstructured":"Skoog M Saarim\u00e4ki JM Gluud C Sheinin M Erlendsson K Aamdal S Transparency and registration in clinical research in the Nordic countries The Nordic Trial Alliance Working Group on Transparency and Registration under NordForsk 2015"},{"issue":"2","key":"10.1002\/14651858.CD012481.pub2-BIB0200|cit200","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.amjcard.2003.09.042","article-title":"Incidence, predictors, in-hospital, and late outcomes of coronary artery perforations","volume":"93","author":"Stankovic","year":"2004","journal-title":"American Journal of Cardiology"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0201|cit201","unstructured":"Stata Statistical Software: Release 14 StataCorp LP 2015"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0202|cit202","doi-asserted-by":"crossref","first-page":"b2393","DOI":"10.1136\/bmj.b2393","article-title":"Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls","volume":"338","author":"Sterne","year":"2009","journal-title":"BMJ"},{"issue":"9591","key":"10.1002\/14651858.CD012481.pub2-BIB0203|cit203","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"Stettler","year":"2007","journal-title":"Lancet"},{"issue":"6","key":"10.1002\/14651858.CD012481.pub2-BIB0204|cit204","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1016\/0002-8703(89)90007-0","article-title":"The spectrum of death after myocardial infarction: a necropsy study","volume":"118","author":"Stevenson","year":"1989","journal-title":"American Heart Journal"},{"issue":"3","key":"10.1002\/14651858.CD012481.pub2-BIB0205|cit205","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1056\/NEJMoa032441","article-title":"A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease","volume":"350","author":"Stone","year":"2004","journal-title":"New England Journal of Medicine"},{"issue":"16","key":"10.1002\/14651858.CD012481.pub2-BIB0206|cit206","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1161\/01.CIR.0000127110.49192.72","article-title":"One-year clinical results with the slow-release, polymer-based, paclitaxel-eluting TAXUS stent: the TAXUS-IV trial","volume":"109","author":"Stone","year":"2004","journal-title":"Circulation"},{"issue":"18","key":"10.1002\/14651858.CD012481.pub2-BIB0207|cit207","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa0910496","article-title":"Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease","volume":"362","author":"Stone","year":"2010","journal-title":"New England Journal of Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012481.pub2-BIB0208|cit208","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1017\/S0266462310001340","article-title":"Drug-eluting stents versus bare-metal stents in acute myocardial infarction: a systematic review and meta-analysis","volume":"27","author":"Suh","year":"2011","journal-title":"International Journal of Technology Assessment in Health Care"},{"issue":"9","key":"10.1002\/14651858.CD012481.pub2-BIB0209|cit209","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/sim.1761","article-title":"What to add to nothing? Use and avoidance of continuity corrections in meta-analysis of sparse data","volume":"23","author":"Sweeting","year":"2004","journal-title":"Statistics in Medicine"},{"issue":"4","key":"10.1002\/14651858.CD012481.pub2-BIB0210|cit210","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1161\/01.CIR.102.4.399","article-title":"Initial and 6-month results of biodegradable poly-l-lactic acid coronary stents in humans","volume":"102","author":"Tamai","year":"2000","journal-title":"Circulation"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0211|cit211","first-page":"14","article-title":"Practical estimates of the effect of publication bias in meta-analysis","volume":"5","author":"Taylor","year":"1998","journal-title":"Australian Epidemiologist"},{"issue":"1","key":"10.1002\/14651858.CD012481.pub2-BIB0212|cit212","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1525-1497.2005.00269.x","article-title":"Prevalence of depression in survivors of acute myocardial infarction","volume":"21","author":"Thombs","year":"2006","journal-title":"Journal of General Internal Medicine"},{"issue":"1","key":"10.1002\/14651858.CD012481.pub2-BIB0213|cit213","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/ije\/dyn179","article-title":"Can trial sequential monitoring boundaries reduce spurious inferences from meta-analyses?","volume":"38","author":"Thorlund","year":"2009","journal-title":"International Journal of Epidemiology"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0214|cit214","unstructured":"Thorlund K Engstr\u00f8m J Wetterslev J Brok J Imberger G Gluud C User manual for Trial Sequential Analysis (TSA) www.ctu.dk\/tsa\/files\/tsa_manual.pdf"},{"issue":"4","key":"10.1002\/14651858.CD012481.pub2-BIB0215|cit215","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.gheart.2012.08.001","article-title":"Third universal definition of myocardial infarction","volume":"7","author":"Thygesen","year":"2012","journal-title":"Global Heart"},{"issue":"3","key":"10.1002\/14651858.CD012481.pub2-BIB0216|cit216","doi-asserted-by":"crossref","first-page":"e59202","DOI":"10.1371\/journal.pone.0059202","article-title":"The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews","volume":"8","author":"Turner","year":"2013","journal-title":"PLoS ONE"},{"issue":"16 Suppl","key":"10.1002\/14651858.CD012481.pub2-BIB0217|cit217","first-page":"S430","article-title":"Burden of disease: medical and economic impact of acute coronary syndromes","volume":"12","author":"Turpie","year":"2006","journal-title":"American Journal of Managed Care"},{"issue":"6","key":"10.1002\/14651858.CD012481.pub2-BIB0218|cit218","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item Short-Form Health Survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Sherbourne","year":"1992","journal-title":"Medical Care"},{"issue":"1","key":"10.1002\/14651858.CD012481.pub2-BIB0219|cit219","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"Journal of Clinical Epidemiology"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0220|cit220","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/1471-2288-9-86","article-title":"Estimating required information size by quantifying diversity in random-effects model meta-analyses","volume":"9","author":"Wetterslev","year":"2009","journal-title":"BMC Medical Research Methodology"},{"issue":"1","key":"10.1002\/14651858.CD012481.pub2-BIB0221|cit221","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s12874-017-0315-7","article-title":"Trial Sequential Analysis in systematic reviews with meta-analysis","volume":"17","author":"Wetterslev","year":"2017","journal-title":"BMC Medical Research Methodology"},{"issue":"9638","key":"10.1002\/14651858.CD012481.pub2-BIB0222|cit222","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/S0140-6736(08)61237-4","article-title":"Acute myocardial infarction","volume":"372","author":"White","year":"2008","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD012481.pub2-BIB0223|cit223","unstructured":"World Health Organization (WHO) Cardiovascular diseases www.who.int\/cardiovascular_diseases\/en\/"},{"issue":"37","key":"10.1002\/14651858.CD012481.pub2-BIB0224|cit224","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1093\/eurheartj\/ehu278","article-title":"2014 ESC\/EACTS Guidelines on myocardial revascularization: The Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)","volume":"35","author":"Windecker","year":"2014","journal-title":"European Heart Journal"},{"issue":"7644","key":"10.1002\/14651858.CD012481.pub2-BIB0225|cit225","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1136\/bmj.39465.451748.AD","article-title":"Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study","volume":"336","author":"Wood","year":"2008","journal-title":"BMJ"},{"issue":"4","key":"10.1002\/14651858.CD012481.pub2-BIB0226|cit226","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.ahj.2003.10.039","article-title":"Clinically important differences in health status for patients with heart disease: an expert consensus panel report","volume":"147","author":"Wyrwich","year":"2004","journal-title":"American Heart Journal"},{"issue":"6","key":"10.1002\/14651858.CD012481.pub2-BIB0227|cit227","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.hlc.2014.01.006","article-title":"Five-year outcomes for first generation drug-eluting stents versus bare-metal stents in patients with ST-segment elevation myocardial infarction: a meta-analysis of randomised controlled trials","volume":"23","author":"Zheng","year":"2014","journal-title":"Heart, Lung & Circulation"},{"issue":"12","key":"10.1002\/14651858.CD012481.pub2-BIB0228|cit228","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD012481","article-title":"Drug-eluting stents versus bare-metal stents for acute coronary syndrome","author":"Feinberg","year":"2016","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cochranelibrary.com\/cdsr\/doi\/10.1002\/14651858.CD012481.pub2\/epdf\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,10]],"date-time":"2023-01-10T19:15:16Z","timestamp":1673378116000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD012481.pub2"}},"subtitle":[],"editor":[{"name":"Cochrane Heart Group","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2017,8,23]]},"references-count":228,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2021,6]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd012481.pub2","relation":{},"ISSN":["1465-1858"],"issn-type":[{"value":"1465-1858","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,23]]}}}